KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Liabilities and Shareholders Equity (2016 - 2025)

Johnson & Johnson's Liabilities and Shareholders Equity history spans 17 years, with the latest figure at $199.2 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 10.61% year-over-year to $199.2 billion; the TTM value through Dec 2025 reached $779.1 billion, up 9.51%, while the annual FY2025 figure was $199.2 billion, 10.61% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $199.2 billion at Johnson & Johnson, up from $192.8 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $199.2 billion in Q4 2025 and bottomed at $166.1 billion in Q4 2023.
  • The 5-year median for Liabilities and Shareholders Equity is $179.2 billion (2021), against an average of $181.7 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity decreased 12.25% in 2024 before it increased 12.62% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $179.2 billion in 2021, then decreased by 2.29% to $175.1 billion in 2022, then decreased by 4.32% to $167.6 billion in 2023, then increased by 7.49% to $180.1 billion in 2024, then increased by 10.61% to $199.2 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Liabilities and Shareholders Equity are $199.2 billion (Q4 2025), $192.8 billion (Q3 2025), and $193.4 billion (Q2 2025).